Vimarsana
Biggest News Aggregation in the World

Murrayb Stein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Murrayb Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Murrayb Stein Today - Breaking & Trending Today

Breakthrough Study Sheds Light on Post-Traumatic Stress Disorder - Vimarsana News

Breakthrough Study Sheds Light on Post-Traumatic Stress Disorder

The Psychiatric Genetics Consortium (PGC), a consortium of researchers led by scientists at University of California San Diego School of Medicine has made significant advancements in the understanding of the neurobiology of post-traumatic stress diso

New Study Links Excess Cannabis Use to Numerous Health Problems - Vimarsana News

New Study Links Excess Cannabis Use to Numerous Health Problems

A comprehensive study conducted by researchers from Yale, involving the analysis of over one million individuals' genomes, has provided new insights into the biology of cannabis use disorder. This study also explores its connections to various psychiatric conditions, the tendency to abuse other subs

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD) - Vimarsana News

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Statistically significant secondary endpoints showed improvements in depressive symptoms and sleep. BNC210 was well-tolerated with a safety profile supporting chronic administration. Company plans to engage with the U.S. Food and Drug Administration (FDA) to discuss the registrational path for BNC210 in PTSD. Webcast and conference call was held 28 September 2023 at 8:00 AM EST (10:00 PM AEST). Please click on the link to watch the replay: http...

Bionomics Announces Positive Topline Results from the Phase - Vimarsana News

Bionomics Announces Positive Topline Results from the Phase

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. ...

Screen for Depression, Anxiety in Most Adults, USPSTF Says - Vimarsana News

Screen for Depression, Anxiety in Most Adults, USPSTF Says

Insufficient evidence remains for suicide screening